Acadia Healthcare (NASDAQ:ACHC) Upgraded at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a sell rating to a hold rating in a research report sent to investors on Thursday, MarketBeat reports. They currently have $70.00 target price on the stock.

A number of other analysts have also recently commented on the company. TD Cowen lifted their price target on Acadia Healthcare from $86.00 to $101.00 and gave the stock an outperform rating in a research report on Friday, March 1st. Royal Bank of Canada reaffirmed an outperform rating and set a $94.00 price target on shares of Acadia Healthcare in a research report on Monday, March 4th. Stephens raised Acadia Healthcare from an equal weight rating to an overweight rating and set a $92.00 price target for the company in a research report on Friday, January 5th. UBS Group lifted their price target on Acadia Healthcare from $88.00 to $102.00 and gave the stock a buy rating in a research report on Wednesday, February 28th. Finally, Mizuho boosted their price objective on Acadia Healthcare from $77.00 to $84.00 and gave the company a neutral rating in a report on Wednesday, March 6th. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of Moderate Buy and a consensus price target of $92.00.

Acadia Healthcare Stock Up 0.3 %

Shares of ACHC stock opened at $73.59 on Thursday. Acadia Healthcare has a 1-year low of $66.49 and a 1-year high of $87.77. The stock’s fifty day moving average price is $78.07 and its 200 day moving average price is $77.70. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.67 and a quick ratio of 0.67. The company has a market cap of $6.80 billion, a price-to-earnings ratio of -294.35, a price-to-earnings-growth ratio of 2.17 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The firm had revenue of $742.80 million for the quarter, compared to the consensus estimate of $727.60 million. During the same period in the previous year, the business earned $0.70 EPS. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. On average, research analysts expect that Acadia Healthcare will post 3.57 earnings per share for the current fiscal year.

Insider Activity at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.80% of the stock is owned by company insiders.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. Headlands Technologies LLC purchased a new position in shares of Acadia Healthcare in the 3rd quarter valued at about $25,000. GAMMA Investing LLC acquired a new position in shares of Acadia Healthcare during the fourth quarter valued at approximately $26,000. Mather Group LLC. acquired a new position in shares of Acadia Healthcare during the first quarter valued at approximately $48,000. Fifth Third Bancorp raised its holdings in shares of Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after acquiring an additional 136 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare during the third quarter valued at approximately $96,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.